Alkermes plc. Debt Securities, Available-for-sale
Alkermes plc. (ALKS) had Debt Securities, Available-for-sale of $179.96 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Assets › Investments
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-07-28
- 2026-06-30: Debt Securities, Available-for-sale $179.96M.
- 2026-03-31: Debt Securities, Available-for-sale $186.53M.
- 2025-12-31: Debt Securities, Available-for-sale $199.65M.
- 2025-09-30: Debt Securities, Available-for-sale $522.39M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2026-06-30 | $179.96M 10-Q · filed 2026-07-28 |
| 2026-03-31 | $186.53M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $199.65M 10-K · filed 2026-02-25 |
| 2025-09-30 | $522.39M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $532.66M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $516.25M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $533.52M 10-K · filed 2025-02-12 |
| 2024-09-30 | $531.35M 10-Q · filed 2024-10-24 |
| 2024-06-30 | $427.22M 10-Q · filed 2024-07-24 |
| 2024-03-31 | $385.26M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $354.09M 10-K · filed 2024-02-21 |
| 2023-09-30 | $346.05M 10-Q · filed 2023-10-25 |
| 2023-06-30 | $239.56M 10-Q · filed 2023-07-26 |
| 2023-03-31 | $369.32M 10-Q · filed 2023-04-26 |
| 2022-12-31 | $445.78M 10-K · filed 2023-02-16 |
| 2022-09-30 | $481.33M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $503.51M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $474.32M 10-Q · filed 2022-04-27 |
| 2021-12-31 | $426.38M 10-K · filed 2022-02-16 |
| 2021-09-30 | $435.89M 10-Q · filed 2021-10-27 |
| 2021-06-30 | $407.34M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $418.75M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $383.17M 10-K · filed 2021-02-11 |
| 2020-09-30 | $352.63M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $347.01M 10-Q · filed 2020-07-29 |
| 2020-03-31 | $370.13M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $407.01M 10-K · filed 2020-02-13 |
| 2019-09-30 | $343.57M 10-Q · filed 2019-10-23 |
| 2019-06-30 | $394.03M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $396.31M 10-Q · filed 2019-04-25 |
| 2018-12-31 | $349.16M 10-K · filed 2019-02-15 |
| 2018-09-30 | $358.86M 10-Q · filed 2018-10-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |